A 17-year-old cisgender girl is seen in clinic 3 days after a new diagnosis of HIV. On physical examination, it is determined that she has a sexual maturity rating (SMR) stage V. She and her current male sex partner are intermittently using condoms, and they are not using any additional birth control measures at this time.
Which one of the following is most accurate regarding current recommendations for the use of dolutegravir in a person with childbearing potential who is not using reliable birth control measures?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 26th, 2023
September 26th, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5